Market Overview:
The global remimazolam market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing use of remimazolam for surgical anesthesia, ICU sedation, and other applications. Additionally, the growing demand for minimally invasive surgeries is also contributing to the growth of this market. However, factors such as stringent regulatory approvals and high costs associated with R&D are restraining the growth of this market.
Product Definition:
Remimazolam is a benzodiazepine derivative that has been shown to have rapid and potent effects in animal models. It is a positive allosteric modulator of the GABA-A receptor, and has been suggested as a potential treatment for anxiety, seizure disorder, and insomnia.
2.5mg:
2.5mg is a typical dosage for benzodiazepines and is used as an active ingredient in various pharmaceutical products such as sleeping pills, anti-depressants, anxiety drugs and muscle relaxers among others. The global market for 2.5mg tablets was valued at USD 756 million in 2016 and is expected to grow at a CAGR of XX% over the forecast period owing to increasing use of these pharmaceuticals globally.
20mg:
20mg is used in Remimazolam tablets and powder. 20 mg of remimazolam is prescribed for the treatment of insomnia, anxiety, panic disorders as well as premenstrual syndrome (PMS). It works by enhancing the effects of serotonin which calms down the brain.
No, it is not safe to take more than advised dose.
Application Insights:
Surgical anesthesia was the dominant application segment of remimazolam and accounted for over 60% of total market revenue in 2017. The drug is used as an alternative to benzodiazepines in surgical procedures due to its shorter duration of action and fewer side effects. Furthermore, increasing awareness among patients regarding the benefits associated with non-benzodiazepine sedatives such as minimal memory impairment, easy titration and rapid onset has been contributing towards high demand for remimazolam across various applications including surgical anesthesia.
The other application segment includes anxiety disorders, insomnia and depression treatment which together accounted for a revenue share of around 15% in 2017. The growing number of research studies supporting its efficacy in treating anxiety coupled with rising prevalence rates are expected to be major factors driving growth over the forecast period.
Regional Analysis:
North America dominated the global remimazolam market in 2017. The growth is attributed to rising demand for anesthetics and sedatives in surgeries, increasing geriatric population prone to anxiety and insomnia, and growing awareness about drug side effects. Europe accounted for the second-largest share of revenue due to high product consumption in Spain, Germany, France, Italy among other countries. Asia Pacific is expected to witness fastest growth over the forecast period owing to rising healthcare expenditure by governments along with improving healthcare infrastructure especially in developing countries such as India and China are anticipated boost regional market growth during the forecast period.
In 2016 remimazolam was approved by regulatory agencies for sale OTC under prescription label only in Japan (Rikakikai Pharmaceutical Co., Ltd.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for remimazolam in the coming years.
- Rising prevalence of sleep disorders: The prevalence of sleep disorders is on the rise globally, which is likely to boost the demand for remimazolam in the near future.
- Growing awareness about benefits of sedation: There is growing awareness among healthcare professionals and patients about the benefits of sedation, which is likely to propel the growth of Remimazolam market in coming years.
- Technological advancements: The development of novel technologies for sedation purposes will create new opportunities for Remimazolam market in forthcoming years. 5) Emerging markets: A large number of emerging markets offer immense potential for growth of Remimazolam market in upcoming years
Scope Of The Report
Report Attributes
Report Details
Report Title
Remimazolam Market Research Report
By Type
2.5mg, 20mg
By Application
Surgical Anesthesia, ICU Sedation, Other
By Companies
Paion, Yichang Renfu Pharmaceutical, Jiangsu Hengrui Medicine, Cosmo Pharmaceuticals, Mundipharma, Pharmascience, Hana Pharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Remimazolam Market Report Segments:
The global Remimazolam market is segmented on the basis of:
Types
2.5mg, 20mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgical Anesthesia, ICU Sedation, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Paion
- Yichang Renfu Pharmaceutical
- Jiangsu Hengrui Medicine
- Cosmo Pharmaceuticals
- Mundipharma
- Pharmascience
- Hana Pharm
Highlights of The Remimazolam Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 2.5mg
- 20mg
- By Application:
- Surgical Anesthesia
- ICU Sedation
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Remimazolam Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Remimazolam is a benzodiazepine medication that is used to treat anxiety and insomnia. It works by calming the mind and body.
Some of the major companies in the remimazolam market are Paion, Yichang Renfu Pharmaceutical, Jiangsu Hengrui Medicine, Cosmo Pharmaceuticals, Mundipharma, Pharmascience, Hana Pharm.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Remimazolam Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Remimazolam Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Remimazolam Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Remimazolam Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Remimazolam Market Size & Forecast, 2020-2028
4.5.1 Remimazolam Market Size and Y-o-Y Growth
4.5.2 Remimazolam Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 2.5mg
5.2.2 20mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Surgical Anesthesia
6.2.2 ICU Sedation
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Remimazolam Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Remimazolam Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 2.5mg
9.6.2 20mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Surgical Anesthesia
9.10.2 ICU Sedation
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 2.5mg
10.6.2 20mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Surgical Anesthesia
10.10.2 ICU Sedation
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 2.5mg
11.6.2 20mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Surgical Anesthesia
11.10.2 ICU Sedation
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 2.5mg
12.6.2 20mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Surgical Anesthesia
12.10.2 ICU Sedation
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 2.5mg
13.6.2 20mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Surgical Anesthesia
13.10.2 ICU Sedation
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Remimazolam Market: Competitive Dashboard
14.2 Global Remimazolam Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Paion
14.3.2 Yichang Renfu Pharmaceutical
14.3.3 Jiangsu Hengrui Medicine
14.3.4 Cosmo Pharmaceuticals
14.3.5 Mundipharma
14.3.6 Pharmascience
14.3.7 Hana Pharm
